| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
REVIEW |
1 Respiratory Medicine, National Heart and Lung Institute, Imperial College Faculty of Medicine, Hammersmith Hospital, London
2 Respiratory Medicine, Rayne Laboratories, University of Edinburgh
Correspondence to:
Correspondence to:
Dr Claire Shovlin, Respiratory Medicine, National Heart and Lung Institute, Imperial College Faculty of Medicine, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK;
c.shovlin{at}ic.ac.uk
Hereditary haemorrhagic telangiectasia (HHT) affects one in 5-8000, and no longer can be viewed as solely causing anaemia (due to nasal and gastrointestinal bleeding) and characteristic mucocutaneous telangiectasia. Arteriovenous malformations commonly occur, and in the pulmonary and cerebral circulations demand knowledge of risks and benefits of asymptomatic screening and treatment. HHT is inherited as an autosomal dominant trait and there is no age cut off when apparently unaffected offspring of an individual with HHT can be told they are unaffected. This review focuses on the evolving evidence base for HHT management, issues regarding pregnancy and prothrombotic treatments, and discusses the molecular and cellular changes that underlie this disease.
Keywords: hereditary haemorrhagic telangiectasia; Osler-Weber-Rendu syndrome
Abbreviations: AVM, arteriovenous malformation; HHT, hereditary haemorrhagic telangiectasia; MRI, magnetic resonance imaging; TGF-ß, transforming growth factor-beta
This article has been cited by other articles:
|
|
 |
|
  G. Schneider, M. Uder, M. Koehler, M. A. Kirchin, A. Massmann, A. Buecker, and U. Geisthoff MR Angiography for Detection of Pulmonary Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia Am. J. Roentgenol., April 1, 2008; 190(4): 892 - 901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J.H. Kuijpers, F.M.M.A. van der Heijden, S. Tuinier, and W.M.A. Verhoeven Hereditary Hemorrhagic Telangiectasia and Psychopathology J Neuropsychiatry Clin Neurosci, May 1, 2007; 19(2): 199 - 200. [Full Text] [PDF]
|
|
|
|
|
|
T. Clayton, K. P. Banks, and L. T. Bui-Mansfield AJR Teaching File: High-Output Cardiac Failure in a Patient with a History of Hereditary Hemorrhagic Telangiectasia. Am. J. Roentgenol., December 1, 2006; 187(6 Suppl): S508 - S510. [Full Text] [PDF]
|
|
|
|
|
|
J. S. Wu, S. Saluja, G. Garcia-Tsao, A. Chong, K. J. Henderson, and R. I. White Jr. Liver Involvement in Hereditary Hemorrhagic Telangiectasia: CT and Clinical Findings Do Not Correlate in Symptomatic Patients Am. J. Roentgenol., October 1, 2006; 187(4): W399 - W405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C J Gallione, J A Richards, T G W Letteboer, D Rushlow, N L Prigoda, T P Leedom, A Ganguly, A Castells, J K Ploos van Amstel, C J J Westermann, et al. SMAD4 mutations found in unselected HHT patients J. Med. Genet., October 1, 2006; 43(10): 793 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. S. Chew and K. P. Banks Imaging of Pheochromocytoma and Incidental Adrenal Lesions: Self-Assessment Module Am. J. Roentgenol., September 1, 2006; 187(3_Supplement): S467 - S469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sabba, G. Pasculli, P. Suppressa, F. D'Ovidio, G. M. Lenato, F. Resta, G. Assennato, and G. Guanti Life expectancy in patients with hereditary haemorrhagic telangiectasia QJM, May 1, 2006; 99(5): 327 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Fernandez-L, F. Sanz-Rodriguez, F. J. Blanco, C. Bernabeu, and L. M. Botella Hereditary Hemorrhagic Telangiectasia, a Vascular Dysplasia Affecting the TGF-{beta} Signaling Pathway. Clin. Med. Res., March 1, 2006; 4(1): 66 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gallitelli, G. Pasculli, T. Fiore, A. Carella, and C. Sabba Emergencies in hereditary haemorrhagic telangiectasia QJM, January 1, 2006; 99(1): 15 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hyodoh, M. Hori, H. Akiba, M. Tamakawa, K. Hyodoh, and M. Hareyama Peripheral Vascular Malformations: Imaging, Treatment Approaches, and Therapeutic Issues RadioGraphics, October 1, 2005; 25(suppl_1): S159 - S171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S G Cole, M E Begbie, G M F Wallace, and C L Shovlin A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5 J. Med. Genet., July 1, 2005; 42(7): 577 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Karabegovic, M Shinawi, U Cymerman, and M Letarte No live individual homozygous for a novel endoglin mutation was found in a consanguineous Arab family with hereditary haemorrhagic telangiectasia J. Med. Genet., November 1, 2004; 41(11): e119 - e119. [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Tille and M.S. Pepper Hereditary Vascular Anomalies: New Insights Into Their Pathogenesis Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1578 - 1590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. C. Duncan and L. Van Der Nest Intralesional Bleomycin Injections for the Palliation of Epistaxis in Hereditary Hemorrhagic Telangiectasia AJNR Am. J. Neuroradiol., August 1, 2004; 25(7): 1144 - 1146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. W. Morrell Screening for Pulmonary Arteriovenous Malformations Am. J. Respir. Crit. Care Med., May 1, 2004; 169(9): 978 - 979. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
